Latest News

New Drug Combination Successfully Treats HIV-Hepatitis C Coinfection
Liver damage progresses at a more rapid pace in patients with HIV.
Long-term survival results after 5 years of ipilimumab therapy in patients with advanced melanoma shows promise.
Researchers evaluate solutions to quality-of-life issues.
Novel oral soluble film is indicated to prevent highly and moderately emetogenic chemotherapy-induced nausea and vomiting.
Sofosbuvir-based therapy offers the potential for high cure rates even in difficult-to-treat patient groups.
Toradol may limit ability of tumor cells to grow and spread.
Toxin may inhibit cell division in cancerous cells.
Pharmacists can play a vital role helping older patients manage their diabetes.


Recently Approved Lung Cancer Drug Provides New First Line Treatment Option
Iressa blocks the activity of an enzyme responsible for regulating pathways implicated in the growth and survival of cancer cells.
Company alleges insurers are taking advantage of program to shift cost of Sovaldi.
PCSK9 inhibitors could cost up to $23.3 billion nationally if widely prescribed.
Pfizer executive discusses the present and future of biosimilars.
Ocrelizumab may shift MS treatment paradigm.
Recently published data from a survey of commercial health plans reveal the latest trends and emerging strategies in oncology management.


David D'Altorio, PharmD, senior vice president of health services at MedImpact Healthcare Systems, Inc, discusses takeaways from the impact of high cost drug launches on specialty pharmacy.

Joseph Morse, president and chief operating officer of Therigy, LLC, discusses how specialty pharmacies can best utilize data analytics.

Amy Grogg, PharmD, senior vice president of Strategy and Commercialization at AmerisourceBergen Specialty Group, discusses methods to improve patient access to specialty medications.

Mitali Nagrecha, counsel at Bergen Pharmacy, discusses tactics specialty pharmacies can use to maintain medication adherence.

SPT Industry Guide

Current Issue

May/June 2015
Volume: 6
Number: 3

Featured Company Profile

HIV Pharmacists: Critical Partners on the HIV Care Team
The American Academy of HIV Medicine has certified thousands of providers with specialist or expert designations.
Company Profile >
Contributor >
Industry Guide >
Market News >
Peer Exchange >
Subscribe >
Specialty Times Resources
About Us
Contact Us
Terms & Conditions
MJH Associates >
Pharmacy Times
American Journal of Managed Care
Targeted Oncology
Physicians' Education Resource
Intellisphere, LLC
666 Plainsboro Road
Building 300
Plainsboro, NJ 08536
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2015
Intellisphere, LLC. All Rights Reserved.